Published in Am J Trop Med Hyg on August 01, 1992
Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A (1997) 9.07
Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, Internet access and review. Trans R Soc Trop Med Hyg (2000) 5.45
Earth observation, geographic information systems and Plasmodium falciparum malaria in sub-Saharan Africa. Adv Parasitol (2000) 4.92
Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med (2012) 4.68
Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya. PLoS Med (2010) 3.78
The risk of a mosquito-borne infection in a heterogeneous environment. PLoS Biol (2004) 3.46
Mapping the ranges and relative abundance of the two principal African malaria vectors, Anopheles gambiae sensu stricto and An. arabiensis, using climate data. Proc Biol Sci (1998) 3.02
Spatial and temporal variation in malaria transmission in a low endemicity area in northern Tanzania. Malar J (2006) 2.65
Interdependence of domestic malaria prevention measures and mosquito-human interactions in urban Dar es Salaam, Tanzania. Malar J (2007) 2.57
Ecological niche partitioning between Anopheles gambiae molecular forms in Cameroon: the ecological side of speciation. BMC Ecol (2009) 2.50
Habitat characterization and spatial distribution of Anopheles sp. mosquito larvae in Dar es Salaam (Tanzania) during an extended dry period. Malar J (2005) 2.39
The influence of urbanisation on measures of Plasmodium falciparum infection prevalence in East Africa. Acta Trop (2005) 2.23
Plasmodium infection and its risk factors in eastern Uganda. Malar J (2010) 2.13
Rapid urban malaria appraisal (RUMA) in sub-Saharan Africa. Malar J (2005) 2.09
Using the SaTScan method to detect local malaria clusters for guiding malaria control programmes. Malar J (2009) 2.06
The availability of potential hosts as a determinant of feeding behaviours and malaria transmission by African mosquito populations. Trans R Soc Trop Med Hyg (2001) 2.03
The unexpected importance of mosquito oviposition behaviour for malaria: non-productive larval habitats can be sources for malaria transmission. Malar J (2005) 1.93
Landscape determinants and remote sensing of anopheline mosquito larval habitats in the western Kenya highlands. Malar J (2006) 1.90
Ensemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccine. PLoS Med (2012) 1.83
Longitudinal study of urban malaria in a cohort of Ugandan children: description of study site, census and recruitment. Malar J (2006) 1.81
Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children. BMC Infect Dis (2004) 1.75
Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda. Malar J (2014) 1.73
Anopheles gambiae distribution and insecticide resistance in the cities of Douala and Yaoundé (Cameroon): influence of urban agriculture and pollution. Malar J (2011) 1.71
Topography-derived wetness indices are associated with household-level malaria risk in two communities in the western Kenyan highlands. Malar J (2008) 1.70
Highly focused anopheline breeding sites and malaria transmission in Dakar. Malar J (2009) 1.63
Multispecies Plasmodium infections of humans. J Parasitol (1999) 1.61
Plasmodium falciparum spatial analysis, western Kenya highlands. Emerg Infect Dis (2005) 1.57
Social and environmental malaria risk factors in urban areas of Ouagadougou, Burkina Faso. Malar J (2009) 1.57
Geographical, meteorological and vectorial factors related to malaria re-emergence in Huang-Huai River of central China. Malar J (2010) 1.54
Plasmodium falciparum induces apoptosis in human mononuclear cells. Infect Immun (1996) 1.50
Knowledge of mosquitos in relation to public and domestic control activities in the cities of Dar es Salaam and Tanga. Bull World Health Organ (1995) 1.43
A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malar J (2011) 1.42
Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials. Malar J (2010) 1.42
Malaria transmission in Dakar: a two-year survey. Malar J (2008) 1.38
Age-adjusted Plasmodium falciparum antibody levels in school-aged children are a stable marker of microgeographical variations in exposure to Plasmodium infection. BMC Infect Dis (2007) 1.37
Wind direction and proximity to larval sites determines malaria risk in Kilifi District in Kenya. Nat Commun (2012) 1.36
Asymptomatic carriage of plasmodium in urban Dakar: the risk of malaria should not be underestimated. PLoS One (2012) 1.27
Potential benefits, limitations and target product-profiles of odor-baited mosquito traps for malaria control in Africa. PLoS One (2010) 1.26
Spatial heterogeneity and temporal evolution of malaria transmission risk in Dakar, Senegal, according to remotely sensed environmental data. Malar J (2010) 1.25
Fever treatment in the absence of malaria transmission in an urban informal settlement in Nairobi, Kenya. Malar J (2009) 1.22
An insight into immunogenic salivary proteins of Anopheles gambiae in African children. Malar J (2007) 1.21
A census-weighted, spatially-stratified household sampling strategy for urban malaria epidemiology. Malar J (2008) 1.12
Defining the origin of Plasmodium falciparum resistant dhfr isolates in Senegal. Acta Trop (2006) 1.10
Malaria transmission in Libreville: results of a one year survey. Malar J (2012) 1.10
Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites. PLoS One (2011) 1.08
Conditions of malaria transmission in Dakar from 2007 to 2010. Malar J (2011) 1.08
Community-owned resource persons for malaria vector control: enabling factors and challenges in an operational programme in Dar es Salaam, United Republic of Tanzania. Hum Resour Health (2011) 1.08
The spatial-temporal clustering of Plasmodium falciparum infection over eleven years in Gezira State, The Sudan. Malar J (2010) 1.06
Population dynamics of Anopheles gambiae s.l. in Bobo-Dioulasso city: bionomics, infection rate and susceptibility to insecticides. Parasit Vectors (2012) 1.06
IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal. Malar J (2012) 1.03
The effects of city streets on an urban disease vector. PLoS Comput Biol (2013) 1.00
Disentangling the effect of local and global spatial variation on a mosquito-borne infection in a neotropical heterogeneous environment. Am J Trop Med Hyg (2010) 0.99
Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors. Malar J (2007) 0.98
A molecular epidemiological study of var gene diversity to characterize the reservoir of Plasmodium falciparum in humans in Africa. PLoS One (2011) 0.98
High mosquito burden and malaria transmission in a district of the city of Douala, Cameroon. BMC Infect Dis (2012) 0.95
Spatio-temporal analysis of malaria within a transmission season in Bandiagara, Mali. Malar J (2013) 0.93
Spatial-temporal analysis of malaria and the effect of environmental factors on its incidence in Yongcheng, China, 2006-2010. BMC Public Health (2012) 0.93
Significance of travel to rural areas as a risk factor for malarial anemia in an urban setting. Am J Trop Med Hyg (2010) 0.93
Risk mapping of Anopheles gambiae s.l. densities using remotely-sensed environmental and meteorological data in an urban area: Dakar, Senegal. PLoS One (2012) 0.91
Landscape movements of Anopheles gambiae malaria vector mosquitoes in rural Gambia. PLoS One (2013) 0.90
Parasite polymorphism and severe malaria in Dakar (Senegal): a West African urban area. PLoS One (2010) 0.89
Geographic coincidence of increased malaria transmission hazard and vulnerability occurring at the periphery of two Tanzanian villages. Malar J (2013) 0.89
Evolution of plastic transmission strategies in avian malaria. PLoS Pathog (2014) 0.88
Modeling larval malaria vector habitat locations using landscape features and cumulative precipitation measures. Int J Health Geogr (2014) 0.88
Seroprevalence of malaria in inhabitants of the urban zone of Antananarivo, Madagascar. Malar J (2006) 0.87
The independent effect of living in malaria hotspots on future malaria infection: an observational study from Misungwi, Tanzania. Malar J (2014) 0.86
Analysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolates. Malar J (2004) 0.86
Agriculture and the promotion of insect pests: rice cultivation in river floodplains and malaria vectors in The Gambia. Malar J (2009) 0.86
Inflammatory cytokine and humoral responses to Plasmodium falciparum glycosylphosphatidylinositols correlates with malaria immunity and pathogenesis. Immun Inflamm Dis (2015) 0.81
Spatial Patterns of Plasmodium falciparum Clinical Incidence, Asymptomatic Parasite Carriage and Anopheles Density in Two Villages in Mali. Am J Trop Med Hyg (2015) 0.81
Defining micro-epidemiology for malaria elimination: systematic review and meta-analysis. Malar J (2017) 0.79
Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity. BMC Med (2015) 0.79
Fine-Scale Mapping by Spatial Risk Distribution Modeling for Regional Malaria Endemicity and Its Implications under the Low-to-Moderate Transmission Setting in Western Cambodia. PLoS One (2016) 0.78
Transmission-blocking strategies: the roadmap from laboratory bench to the community. Malar J (2016) 0.77
Environmental determinant of malaria cases among travellers. Malar J (2013) 0.77
Relationship between Antibody Levels, IgG Binding to Plasmodium falciparum-Infected Erythrocytes, and Disease Outcome in Hospitalized Urban Malaria Patients from Dakar, Sénégal. Biomed Res Int (2016) 0.77
Evidence for perennial malaria in rural and urban areas under the Sudanian climate of Kandi, Northeastern Benin. Parasit Vectors (2014) 0.76
Genetic relatedness analysis reveals the cotransmission of genetically related Plasmodium falciparum parasites in Thiès, Senegal. Genome Med (2017) 0.75
A novel method for mapping village-scale outdoor resting microhabitats of the primary African malaria vector, Anopheles gambiae. Malar J (2016) 0.75
West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia. Am J Trop Med Hyg (2016) 0.75
Marked Rise in the Prevalence of Asymptomatic Plasmodium falciparum Infection in Rural Gabon. PLoS One (2016) 0.75
Population Density, Climate Variables and Poverty Synergistically Structure Spatial Risk in Urban Malaria in India. PLoS Negl Trop Dis (2016) 0.75
Continental-scale patterns of pathogen prevalence: a case study on the corncrake. Evol Appl (2014) 0.75
Perceived malaria in the population of an urban setting: a skipped reality in Dakar, Senegal. Malar J (2012) 0.75
Risk factors for Anopheles mosquitoes in rural and urban areas of Blantyre District, southern Malawi. Malawi Med J (2016) 0.75
Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med (1990) 5.04
The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg (1994) 4.34
Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg (1991) 4.16
Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun (1992) 3.42
Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med (1995) 3.36
Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood (1994) 3.05
Fast emergence of Plasmodium falciparum resistance to halofantrine. Lancet (1993) 3.03
Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat Med (2000) 2.70
Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by the polymerase chain reaction. Trans R Soc Trop Med Hyg (1996) 2.65
Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol (1999) 2.39
Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect Immun (1986) 2.14
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature (1987) 2.02
The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect Immun (1998) 2.00
Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). Am J Trop Med Hyg (1996) 1.98
Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science (1986) 1.81
The spread of tick-borne borreliosis in West Africa and its relationship to sub-Saharan drought. Am J Trop Med Hyg (1996) 1.78
Rapid turnover of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area. Am J Trop Med Hyg (1996) 1.76
Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum. Infect Immun (1983) 1.74
Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal. Infect Immun (2000) 1.68
Effector cells involved in nonspecific and antibody-dependent mechanisms directed against Plasmodium falciparum blood stages in vitro. Infect Immun (1989) 1.61
Complete development of hepatic stages of Plasmodium falciparum in vitro. Science (1985) 1.58
Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection. Parasite Immunol (2004) 1.51
Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum. J Exp Med (2000) 1.50
Epidemiological correlation between levels of antibodies promoting merozoite phagocytosis of Plasmodium falciparum and malaria-immune status. Infect Immun (1987) 1.48
Enhanced Plasmodium falciparum merozoite phagocytosis by monocytes from immune individuals. Infect Immun (1982) 1.46
Evaluation under field conditions of the colourimetric DELI-microtest for the assessment of Plasmodium falciparum drug resistance. Trans R Soc Trop Med Hyg (2001) 1.42
Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent. Malar J (2006) 1.42
Tick-borne borreliosis in west Africa. Lancet (1991) 1.40
Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur J Immunol (1997) 1.39
Surveillance of malaria in European Union countries. Euro Surveill (1998) 1.37
Malaria morbidity among children exposed to low seasonal transmission in Dakar, Senegal and its implications for malaria control in tropical Africa. Am J Trop Med Hyg (1993) 1.34
Cultivation of the liver forms of Plasmodium vivax in human hepatocytes. Nature (1984) 1.33
Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. Bull World Health Organ (1990) 1.30
Species- and stage-specific antigens in exoerythrocytic stages of Plasmodium falciparum. Am J Trop Med Hyg (1984) 1.30
Impaired cell-mediated immunity in Plasmodium falciparum-infected patients with high-parasitemia and cerebral malaria. Clin Immunol Immunopathol (1983) 1.26
[Anopheles of Senegal. An annotated and illustrated list]. Bull Soc Pathol Exot (1994) 1.26
Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. I. Stable figures of prevalence of chloroquine- and quinine-resistant isolates in the original foci. Am J Trop Med Hyg (1992) 1.26
Antibodies in falciparum malaria: what matters most, quantity or quality? Mem Inst Oswaldo Cruz (1992) 1.23
A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes. J Immunol (1996) 1.16
A novel merozoite surface antigen of Plasmodium falciparum (MSP-3) identified by cellular-antibody cooperative mechanism antigenicity and biological activity of antibodies. Mem Inst Oswaldo Cruz (1994) 1.16
A case of autochthonous Plasmodium vivax malaria, Corsica, August 2006. Euro Surveill (2006) 1.16
Reaction to injectable collagen: results in animal models and clinical use. Plast Reconstr Surg (1987) 1.15
Imported Plasmodium vivax malaria in France: geographical origin and report of an atypical case acquired in Central or Western Africa. Acta Trop (2001) 1.14
Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels. Scand J Immunol (2004) 1.14
[Immuno-electro-diffusion on cellulose acetate membrane for serological testing in human malaria (author's transl)]. Pathol Biol (Paris) (1978) 1.14
Parasite-derived mitogenic activity for human T cells in Plasmodium falciparum continuous cultures. Infect Immun (1981) 1.13
Antibody-dependent ingestion of P. falciparum merozoites by human blood monocytes. Parasite Immunol (1983) 1.12
Premunition against Plasmodium falciparum in a malaria hyperendemic village in Myanmar. Trans R Soc Trop Med Hyg (2001) 1.11
The interferon compartment of the immune response in human malaria: II. Presence of serum-interferon gamma following the acute attack. J Interferon Res (1985) 1.11
Antagonism of chloroquine with other antimalarials. Trans R Soc Trop Med Hyg (1988) 1.10
Protection against malaria induced by irradiated sporozoites. Lancet (1990) 1.10
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. Infect Immun (2001) 1.10
Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen. Eur J Immunol (1997) 1.10
Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing. Vaccine (2000) 1.09
A comparative study of three methods of detection of Borrelia crocidurae in wild rodents in Senegal. Trans R Soc Trop Med Hyg (1995) 1.08
Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. Br J Cancer (1998) 1.06
Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance. Am J Trop Med Hyg (1992) 1.05
High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules. Vaccine (2000) 1.05
N-acetylcysteine decreases severity of acute pancreatitis in mice. Pancreas (2000) 1.04
Site and mechanical conditions for failure of skeletal muscle in experimental strain injuries. J Appl Physiol (1985) (1993) 1.03
Immune mechanisms underlying the premunition against Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz (1994) 1.03
[Current data on malaria in metropolitan France]. Med Trop (Mars) (2002) 1.02
Patterns of in vitro resistance to chloroquine, quinine, and mefloquine of Plasmodium falciparum in Cameroon, 1985-1986. Am J Trop Med Hyg (1988) 1.02
Naturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro. Infect Immun (1994) 1.02
High titres of anti-T antibodies and other haemagglutinins in human malaria. Clin Exp Immunol (1982) 1.02
Circulating interferon in patients with Plasmodium falciparum, P. ovale and P. vivax malaria. Trans R Soc Trop Med Hyg (1982) 1.01
High level of sensitivity to chloroquine of 72 Plasmodium falciparum isolates from southern Cameroon in January 1985. Am J Trop Med Hyg (1986) 1.01
Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c. Infect Immun (2009) 1.01
Generation of reactive oxygen species in whole blood from patients with acute falciparum malaria. Parasite Immunol (1987) 1.01
A multidot immunobinding assay for the serodiagnosis of tuberculosis. Comparison with an enzyme-linked immunosorbent assay. J Immunol Methods (1988) 1.01
Plasmodium falciparum in vitro culture: improvements using umbilical cord serum and medium modifications. Tropenmed Parasitol (1980) 1.00
The Plasmodium falciparum knob-associated PfEMP3 antigen is also expressed at pre-erythrocytic stages and induces antibodies which inhibit sporozoite invasion. Mol Biochem Parasitol (2001) 0.99
Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice. Eur J Immunol (2001) 0.99
Toxocaral visceral larva migrans after ingestion of raw lamb liver. Clin Infect Dis (1992) 0.98
Human lymphocyte responses to Plasmodium falciparum merozoite antigens. A functional assay of protective immunity? Trans R Soc Trop Med Hyg (1985) 0.98
Nutritional status, growth and sleep habits among Senegalese adolescent girls. Eur J Clin Nutr (2004) 0.98
Rodent malaria in the natural host--irradiated sporozoites of Plasmodium berghei induce liver-stage specific immune responses in the natural host Grammomys surdaster and protect immunized Grammomys against P. berghei sporozoite challenge. Afr J Med Med Sci (2001) 0.97
Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies. Antimicrob Agents Chemother (2001) 0.97
DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge. Infect Immun (2001) 0.97
Impairment of Plasmodium falciparum-specific antibody response in severe malaria. J Clin Microbiol (1990) 0.97
Fast immunopurification of small amounts of specific antibodies on peptides bound to ELISA plates. J Immunol Methods (1993) 0.96
Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium. Mem Inst Oswaldo Cruz (2007) 0.96
Evidence for diversity of Plasmodium falciparum sporozoite surface antigens derived from analysis of antibodies elicited in humans. Infect Immun (1990) 0.95
Malaria diagnosis: standardization of a polymerase chain reaction for the detection of Plasmodium falciparum parasites in individuals with low-grade parasitemia. Parasitol Res (1996) 0.94
Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF. Genes Immun (2004) 0.92
Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo. Infect Immun (2001) 0.92
Expression of the erythrocyte-binding antigen 175 in sporozoites and in liver stages of Plasmodium falciparum. J Infect Dis (2001) 0.92
Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys. Infect Immun (1998) 0.92
Plasmodium falciparum: studies on mature exoerythrocytic forms in the liver of the chimpanzee, Pan troglodytes. Exp Parasitol (1990) 0.91
Secondary structure and immunogenicity of hybrid synthetic peptides derived from two Plasmodium falciparum pre-erythrocytic antigens. J Immunol (1990) 0.91
Aspects of immunity for the AMA-1 family of molecules in humans and non-human primates malarias. Mem Inst Oswaldo Cruz (1994) 0.91
Activation of phagocyte oxidative metabolism by opsonized Plasmodium falciparum merozoites. Acta Trop (1990) 0.90